LAB's "Celebrity Charades" Benefit Will Be a "Battle of Good vs. Evil" Oct. 29 | Playbill

Related Articles
News LAB's "Celebrity Charades" Benefit Will Be a "Battle of Good vs. Evil" Oct. 29 LAByrinth Theater Company has set the date for its fifth annual "Celebrity Charades" benefit, this year subtitled "The Battle of Good vs. Evil."

DKNY, GQ and Stella Artois serve as sponsors for the Oct. 29 event at New York City's St. Paul's Hall.

Artistic director John Ortiz along with co-artistic directors Philip Seymour Hoffman and John Gould Rubin (also serves as executive director) invite friends and fans to "watch four celebrity teams battle for victory in a hilarious speed charades competition!" as reads an announcement.

The evening will also honor Bennington College as The Dave Hogue Award recipient. The prize — presented for "artistic courage and outstanding dedication to LAByrinth Theater Company" — has previously been presented to Daryl Roth, Ira Pittelman, Madonna and George C. Wolfe.

To revisit the results from last year's event — featuring such stars as Daphne Rubin Vega, Billy Crudup, Gina Gershon, Bobby Cannavale, Sam Rockwell, Julianna Margulies, Justin Theroux and Robin Williams — visit Playbill.com's recap of the benefit.

All proceeds from this event will support LAB's current season. The troupe will open the 2007-2008 lineup with Bob Glaudini's A View from 151st Street (starting Oct. 5) and continue with Brett C. Leonard's Unconditional (directed by Mark Wing-Davey) and Stephen Adly Guirgis' The Little Flower of East Orange (directed by Hoffman). The company will also present developmental runs of Rebecca Cohen's Penalties & Interest and Scott Hudson's Sweet Storm for its 16th season. For tickets to the "Celebrity Charades" event at St. Paul's Hall (Columbus Ave. at 60 St.), call (212) 513-1014 or email [email protected]. For more information visit labtheater.org.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!